Back to Search
Start Over
Loxapine, an antipsychotic drug, suppresses intracellular multiple-antibiotic-resistant Salmonella enterica serovar Typhimurium in macrophages.
- Source :
-
Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi [J Microbiol Immunol Infect] 2019 Aug; Vol. 52 (4), pp. 638-647. Date of Electronic Publication: 2019 Jun 08. - Publication Year :
- 2019
-
Abstract
- Background: The emergence of multiple-antibiotic-resistant (MAR) Salmonella has been a serious threat worldwide. Salmonella can invade into host cells and evade the attacks of host humoral defenses and antibiotics. Thus, a new antibacterial agent capable of inhibiting intracellular Salmonella is highly needed.<br />Methods: The anti-intracellular activity and cytotoxicity of drugs on intracellular bacteria and macrophages were assayed using intracellular CFU assay and MTT cell viability assay, respectively. The uptake of gentamicin into macrophage and the effect of autophagy inhibitor on loxapine's anti-intracellular Salmonella activity were assessed by using image-based high-content system. The expression of bacterial genes was measured by real-time PCR. The efflux pump activity of bacteria was measured by Hoechst accumulation assays.<br />Results: With our efforts, an antipsychotic drug, loxapine, was identified to exhibit high potency in suppressing intracellular MAR S. Typhimurium, Staphylococcus aureus, Shigella flexneri or Yersinia enterocolitica. Subsequent investigations indicated that loxapine's anti-intracellular bacteria activity was not associated with increased penetration of gentamicin into bacteria and macrophages. Loxapine didn't inhibit bacterial growth in broth at concentration up to 500 μM and has no effect on Salmonella's type III secretion system genes' expression. Blockage of autophagy also didn't reverse loxapine's anti-intracellular activity. Lastly, loxapine suppressed bacterial efflux pump activity in all bacteria tested.<br />Conclusion: Altogether, our data suggested that loxapine might suppress intracellular bacteria through inhibiting of bacterial efflux pumps. In light of its unique activity, loxapine represents a promising lead compound with translational potential for the development of a new antibacterial agent against intracellular bacteria.<br /> (Copyright © 2019. Published by Elsevier B.V.)
- Subjects :
- Animals
Autophagy drug effects
Bacterial Proteins genetics
Cell Survival drug effects
Colony Count, Microbial
Drug Resistance, Multiple, Bacterial drug effects
Fluoroquinolones pharmacology
Gene Expression Regulation, Bacterial drug effects
Gentamicins pharmacology
Membrane Transport Proteins drug effects
Membrane Transport Proteins genetics
Mice
Microbial Sensitivity Tests
Phenothiazines pharmacology
RAW 264.7 Cells
Salmonella typhimurium genetics
Salmonella typhimurium growth & development
Serogroup
Shigella flexneri drug effects
Staphylococcus aureus drug effects
Type III Secretion Systems drug effects
Type III Secretion Systems genetics
Yersinia enterocolitica drug effects
Anti-Bacterial Agents pharmacology
Antipsychotic Agents pharmacology
Loxapine pharmacology
Macrophages microbiology
Salmonella typhimurium drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 1995-9133
- Volume :
- 52
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi
- Publication Type :
- Academic Journal
- Accession number :
- 31239204
- Full Text :
- https://doi.org/10.1016/j.jmii.2019.05.006